Research Article
Seven Months after Mild COVID-19: A Single-Centre Controlled Follow-Up Study in the District of Constance (FSC19-KN)
| | | SARS-CoV-2, n = 206 | Control, n = 206 | Missing values, SARS-CoV-2/control |
| | Demographics/biometrics | | Age (years) | 47.0 ± 15.2 | 47.0 ± 15.0 | 0/0 | | 18–39 (no. (%)) | 69 (33.5) | 63 (30.6) | 0/0 | | 40 (no. (%)) | 93 (45.1) | 97 (47.1) | 0/0 | | 60–79 (no. (%)) | 43 (20.9) | 46 (22.3) | 0/0 | | ≥80 (no. (%)) | 1 (0.01) | 0 (0) | 0/0 |
| | Gender | | Male (no. (%)) | 86 (41.8) | 86 (41.8) | 0/0 | | Female (no. (%)) | 120 (58.2) | 120 (58.2) | 0/0 |
| | Body mass index (kg/m2) | 25.3 ± 4.0 | 24.8 ± 4.3 | 4/0 |
| | Cardiovascular risk factors | | Diabetes mellitus (no. (%)) | 1 (0.5) | 1 (0.5) | 0/0 | | Arterial hypertension (no. (%)) | 27 (13.1) | 27 (13.1) | 0/0 | | Hypercholesterolemia (no. (%)) | 24 (11.6) | 15 (7.3) | 2/0 | | Smoking (no. (%)) | 79 (36.9) | 79 (36.9) | 0/0 | | Family history of coronary artery disease (no. (%)) | 37 (18.9) | 36 (17.5) | 3/2 |
| | Clinical history | | Chronic obstructive pulmonary disease (no. (%)) | 3 (1.5) | 2 (1.0) | 10/6 | | Interstitial lung disease (no. (%)) | 0 (0.0) | 0 (0.0) | 9/7 | | Pulmonary embolism (no. (%)) | 1 (0.5) | 1 (0.5) | 8/7 | | Deep vein thrombosis (no. (%)) | 2 (1.0) | 4 (1.9) | 9/7 | | Asthma (no. (%)) | 18 (8.9) | 8 (3.9) | 22/12 | | Myocardial infarction (no. (%)) | 3 (1.5) | 3 (1.5) | 0/0 | | Transient ischemic attack/stroke (no. (%)) | 2 (1.0) | 2 (1.0) | 0/0 | | Coronary artery disease (no. (%)) | 4 (1.9) | 4 (1.9) | 0/0 | | Peripheral artery disease (no. (%)) | 1 (0.5) | 1 (0.5) | 1/0 |
|
|
Data are given as absolute value (percentage)/mean ± standard deviation.
|
